Cargando…
Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653107/ https://www.ncbi.nlm.nih.gov/pubmed/33209591 http://dx.doi.org/10.21037/tlcr-20-477 |
| _version_ | 1783607833379471360 |
|---|---|
| author | Cerfolio, Robert J. Moore, William H. |
| author_facet | Cerfolio, Robert J. Moore, William H. |
| author_sort | Cerfolio, Robert J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7653107 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76531072020-11-17 Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer Cerfolio, Robert J. Moore, William H. Transl Lung Cancer Res Editorial AME Publishing Company 2020-10 /pmc/articles/PMC7653107/ /pubmed/33209591 http://dx.doi.org/10.21037/tlcr-20-477 Text en 2020 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Cerfolio, Robert J. Moore, William H. Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer |
| title | Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer |
| title_full | Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer |
| title_fullStr | Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer |
| title_full_unstemmed | Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer |
| title_short | Can CT radiomics differentiate benign from malignant N2 adenopathy in non-small cell lung cancer |
| title_sort | can ct radiomics differentiate benign from malignant n2 adenopathy in non-small cell lung cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653107/ https://www.ncbi.nlm.nih.gov/pubmed/33209591 http://dx.doi.org/10.21037/tlcr-20-477 |
| work_keys_str_mv | AT cerfoliorobertj canctradiomicsdifferentiatebenignfrommalignantn2adenopathyinnonsmallcelllungcancer AT moorewilliamh canctradiomicsdifferentiatebenignfrommalignantn2adenopathyinnonsmallcelllungcancer |